|
⚲
|
| Keyboard |
| McCann Joe A
✚
|
|
|---|---|
| CIK # | 0001868644 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001868644] | |
| 4 | [0001868644] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| POINT Biopharma Global Inc | |
| McCann Joe A |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
POINT Biopharma Global Inc PNT
Stock Option (Right to Buy) · derivative
|
2023-12-27 | Disposed to issuer | 381,795 | ||
|
POINT Biopharma Global Inc PNT
Stock Option (Right to Buy) · derivative
|
2023-12-27 | Disposed to issuer | 692,643 | ||
|
POINT Biopharma Global Inc PNT
Common Stock
|
2023-12-22 | Tender | 2,160 | ||
|
POINT Biopharma Global Inc PNT
Common Stock
|
2023-12-22 | Tender | 3,494,153 | ||
|
POINT Biopharma Global Inc PNT
Common Stock
|
2023-11-06 | Gift | 120,000 | $0.00 | |
|
POINT Biopharma Global Inc PNT
Stock Option (Right to Buy) · derivative
|
2023-03-28 | Grant | 692,643 | $0.00 | |
|
POINT Biopharma Global Inc PNT
Common Stock
|
2022-11-29 | Buy | 2,160 | $6.64 | 14,342 |
|
POINT Biopharma Global Inc PNT
Stock Option (Right to Buy) · derivative
|
2022-03-29 | Grant | 381,795 | $0.00 | |
|
POINT Biopharma Global Inc PNT
Common Stock
|
2021-06-30 | Grant | 3,614,153 |